N- [3-(3-substituted-pyrazolo[1,5-a]pyrimidi n-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto

Details for Australian Patent Application No. 2004263278 (hide)

Owner Ferrer Internacional, S.A.

Inventors Palomer, Albert; Guglietta, Antonio; Anglada, Luis; Princep, Marta

Agent Shelston IP

Pub. Number AU-B-2004263278

PCT Pub. Number WO2005/014597

Priority 200301746 24.07.03 ES; 200401697 12.07.04 ES

Filing date 22 July 2004

Wipo publication date 17 February 2005

Acceptance publication date 12 March 2009

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/014597 Priority application(s): WO2005/014597

12 March 2009 Application Accepted

  Published as AU-B-2004263278

9 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263285-Stable modifications of tegaserod hydrogen maleate

2004263277-7-substituted 3-nitro-pyrazolo `1,5-a! pyrimidines